China Resources Boya Bio pharmaceutical Group Co Ltd
SZSE:300294
China Resources Boya Bio pharmaceutical Group Co Ltd
SZSE:300294
Price:
21.93
CNY
-1.75%
Market Cap:
¥11.1B
Relative Value
The Relative Value of one
China Resources Boya Bio pharmaceutical Group Co Ltd
stock under the Base Case scenario is
21.94
CNY.
Compared to the current market price of 21.93 CNY,
China Resources Boya Bio pharmaceutical Group Co Ltd
is
Fairly Valued.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
Relative Value
Base Case
21.94
CNY
Fairly Valued
Multiples Across Competitors
Competitors Multiples
China Resources Boya Bio pharmaceutical Group Co Ltd Competitors
China Resources Boya Bio pharmaceutical Group Co Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CN |
|
China Resources Boya Bio pharmaceutical Group Co Ltd
SZSE:300294
|
11.1B CNY | 5.6 | 33.8 | 33.3 | 33.3 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 643 258.8 | -159 901.4 | -194 171.3 | -191 955.6 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
403.9B USD | 6.8 | 172.1 | 16.6 | 23.6 | |
| US |
|
Astria Therapeutics Inc
NASDAQ:ATXS
|
326.4B USD | 462 374.5 | -2 631.9 | -2 377 | -2 377 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
204.6B USD | 5.6 | 26.5 | 15.2 | 15.2 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
185.7B USD | 6.3 | 21.8 | 14.8 | 14.8 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
122.5B USD | 10.2 | 31 | 23.7 | 24.7 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 094 | -534.3 | -581.8 | -566.3 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
82.7B USD | 5.8 | 18.4 | 13.9 | 15.9 | |
| NL |
|
argenx SE
XBRU:ARGX
|
43B EUR | 14.2 | 33.5 | 57.5 | 59 | |
| AU |
|
CSL Ltd
ASX:CSL
|
70.7B AUD | 3.1 | 16.3 | 11.2 | 14 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
